secwatch.observer — SEC 8-K summary
======================================

Issuer:     GoodRx Holdings, Inc. (GDRX)
CIK:        0001809519
Form:       8-K
Filed at:   2024-10-28T23:59:59+00:00
Accession:  0001809519-24-000188
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GoodRx adds IQVIA CFO Bruehlman to board; Bezdek extends contract with no severance
--------------------------------------------------------------------------------

- Ronald E. Bruehlman (IQVIA CFO) elected to Board and as Audit & Risk Committee chair, effective Nov 8, 2024.
- Director Julie Bradley resigns Nov 8 due to personal commitments; no disagreement with company.
- Chief Mission Officer Douglas Hirsch ends employment Oct 25; stays on Board as non-employee director.
- Chairman Trevor Bezdek's employment extended through Oct 25, 2025; 2025 cash bonus target 100% of salary; no severance.
- Bruehlman receives $420K RSU (3-year vest) and $132K pro-rated annual RSU; eligible for standard director cash retainers.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1809519/000180951924000188/0001809519-24-000188-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1809519/000180951924000188/gdrx-20241022.htm
  HTML page:      https://secwatch.observer/filing/0001809519-24-000188

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer